EWBC
East West Bancorp, Inc.
EWBC's fundamentals are strong, but it looks expensive: trading at 12x earnings, above its usual 11x. Analysts expect earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
EWBC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
EWBC's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EWBC.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
EWBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $84.09 | -36% |
| Fair | 11x | $115 | -13% |
| Forward | 11x | $131 | — |
| Current | 12x | $131 | — |
| Expensive | 13x | $141 | +7.8% |
Historical ranges are pointers, not guarantees.
EWBC's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
EWBC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for EWBC, with profitability holding steady. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EWBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.47 | +9.1% |
| Q3 2026 | $10.51 | +16% |
| Q2 2026 | $10.40 | +21% |
| Q1 2026 | $10.01 | +19% |
| Q4 2025 | $9.52 | +14% |
| Q3 2025 | $9.07 | +15% |
| Q2 2025 | $8.56 | +9.7% |
| Q1 2025 | $8.38 | +5.5% |
| Q4 2024 | $8.33 | +1.8% |
EWBC has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
EWBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $822.7M | +5.7% |
| Q2 2026 | $791.1M | +12% |
| Q1 2026 | $773.7M | +12% |
| Q4 2025 | $758.3M | +12% |
| Q3 2025 | $778M | +18% |
| Q2 2025 | $703.3M | +10% |
| Q1 2025 | $692.3M | +7.5% |
| Q4 2024 | $674.4M | +3% |
EWBC's revenue has grown year over year for nine quarters in a row: $823M last quarter, up 5.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 60% | +0.4 points |
| Q2 2026 | 59% | +1.9 points |
| Q1 2026 | 59% | +2.6 points |
| Q4 2025 | 62% | +8.8 points |
| Q3 2025 | 60% | +0.6 points |
| Q2 2025 | 57% | +0.1 points |
| Q1 2025 | 57% | -1.3 points |
| Q4 2024 | 53% | +2.8 points |
EWBC has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
EWBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $450.5M | +94% |
| Q2 2026 | $587.9M | +111% |
| Q1 2026 | $329.6M | +19% |
| Q4 2025 | $713.4M | +43% |
| Q3 2025 | $231.7M | -40% |
| Q2 2025 | $278.7M | +7.5% |
| Q1 2025 | $277.9M | +4.4% |
| Q4 2024 | $500.1M | -11% |
EWBC has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
EWBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +160K shares |
| 1 year | -0.3% | -481K shares |
| 3 years | -2.6% | -3.7M shares |
| 5 years | -3.3% | -4.7M shares |
| Available history | -5.4% | -7.9M shares |
EWBC has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $669,000 |
| Q2 2026 | $1,000 |
| Q1 2026 | $97.8M |
| Q4 2025 | $1M |
| Q3 2025 | $25.4M |
| Q2 2025 | $3.7M |
| Q1 2025 | $85.4M |
| Q4 2024 | $19.9M |
EWBC spent $100M buying back its own shares over the past year, down 26% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
EWBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -2.5x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -2.5x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -3.1x | Net Cash |
EWBC has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like EWBC.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
EWBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.0 | Neutral |
| Stochastic | 56.4 | Neutral |
EWBC's weekly RSI is 57 (neutral) and its Stochastic is 56 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
EWBC PE vs Financial Services Sector
| Metric | EWBC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 4.1% below |
| PE % | 69 | 63 | 6 pts above |
EWBC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
EWBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $128.5 | 2.1% above |
| 20 week MA | $130.0 | 0.9% above |
| 50 week MA | $122.2 | 7.3% above |
| 100 week MA | $109.8 | 19% above |
| 200 week MA | $89.9 | 46% above |
EWBC has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
EWBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.8 | $50.4 | +3.3% |
| 2021 | $50.4 | $77.4 | +54% |
| 2022 | $77.4 | $64.9 | -16% |
| 2023 | $64.9 | $72.0 | +11% |
| 2024 | $72.0 | $96.7 | +34% |
| 2025 | $96.7 | $116.0 | +20% |
| 2026 YTD | $116.0 | $131.2 | +13% |
EWBC has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.